The obesity-breast cancer link: a multidisciplinary perspective
EN Devericks, MS Carson, LE McCullough… - Cancer and Metastasis …, 2022 - Springer
Obesity, exceptionally prevalent in the USA, promotes the incidence and progression of
numerous cancer types including breast cancer. Complex, interacting metabolic and …
numerous cancer types including breast cancer. Complex, interacting metabolic and …
Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta-Analysis
CM Nielson, LC Bylsma, JP Fryzek, HA Saad… - The …, 2021 - academic.oup.com
Background Chemotherapy-induced toxicities lead to therapy dose reduction or delay,
affecting patient outcomes. This systematic review and meta-analysis evaluated the impact …
affecting patient outcomes. This systematic review and meta-analysis evaluated the impact …
Appropriate systemic therapy dosing for obese adult patients with cancer: ASCO guideline update
PURPOSE To provide recommendations for appropriate dosing of systemic antineoplastic
agents in obese adults with cancer. METHODS A systematic review of the literature collected …
agents in obese adults with cancer. METHODS A systematic review of the literature collected …
Sarcopenia and malignancies: epidemiology, clinical classification and implications
FM Zhang, HF Wu, HP Shi, Z Yu, CL Zhuang - Ageing Research Reviews, 2023 - Elsevier
Sarcopenia is a progressive systemic skeletal muscle disorder characterized by a
pathological decline in muscle strength, quantity, and quality, which frequently affects the …
pathological decline in muscle strength, quantity, and quality, which frequently affects the …
Routine cancer treatments and their impact on physical function, symptoms of cancer-related fatigue, anxiety, and depression
NP Grusdat, A Stäuber, M Tolkmitt, J Schnabel… - Supportive Care in …, 2022 - Springer
Background and purpose Breast cancer can be a major challenge for affected women.
Knowledge of the physical function, symptoms of cancer-related fatigue, anxiety, and …
Knowledge of the physical function, symptoms of cancer-related fatigue, anxiety, and …
Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis
A Surov, M Pech, D Gessner, M Mikusko, T Fischer… - Clinical Nutrition, 2021 - Elsevier
Background & aims The purpose of this meta-analysis was to summarize the published data
regarding associations between occurrence of severe treatment related toxicity and low …
regarding associations between occurrence of severe treatment related toxicity and low …
Skeletal muscle deconditioning in breast cancer patients undergoing chemotherapy: current knowledge and insights from other cancers
Breast cancer represents the most commonly diagnosed cancer while neoadjuvant and
adjuvant chemotherapies are extensively used in order to reduce tumor development and …
adjuvant chemotherapies are extensively used in order to reduce tumor development and …
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
Abstract Recently updated American Society of Clinical Oncology (ASCO) guidelines for
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in …
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in …
The past, present, and future of chemotherapy with a focus on individualization of drug dosing
L DeRidder, DA Rubinson, R Langer… - Journal of Controlled …, 2022 - Elsevier
While there have been rapid advances in develo** new and more targeted drugs to treat
cancer, much less progress has been made in individualizing dosing. Even though the …
cancer, much less progress has been made in individualizing dosing. Even though the …
Combined Chemo-and Photothermal Therapies of Non-Small Cell Lung Cancer Using Polydopamine/Au Hollow Nanospheres Loaded with Doxorubicin
X Zhang, B Xu, J Ni, Y **ang, Z He - International Journal of …, 2024 - Taylor & Francis
Purpose The chemotherapeutic agent doxorubicin (DOX) is limited by its cardiotoxicity,
posing challenges in its application for non-small cell lung cancer (NSCLC). This study aims …
posing challenges in its application for non-small cell lung cancer (NSCLC). This study aims …